• Freedom
  • Innovation
  • Growth

A Long History: IPI's Work on Drug Importation Risks

Institute for Policy Innovation

The Trump Administration has officially proposed legalizing the importation of drugs from Canada, a policy that’s been the focus of intense debate for over three decades.

For over 16 years, the Institute for Policy Innovation has released numerous publications warning the risks of such a scheme cannot be overstated—foremost the public health danger, since it is impossible for the U.S. to guarantee the safety of imported drugs.

The following is a history of IPI’s research into the question of whether the U.S. should open its drug market to imported pharmaceuticals.


blog comments powered by Disqus